Komipharm International Co. Ltd (041960) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.013x

Based on the latest financial reports, Komipharm International Co. Ltd (041960) has a cash flow conversion efficiency ratio of 0.013x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩946.94 Million ≈ $641.73K USD) by net assets (₩72.06 Billion ≈ $48.83 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Komipharm International Co. Ltd (041960) market capitalisation for the company's overall valuation and market capitalisation.

Komipharm International Co. Ltd - Cash Flow Conversion Efficiency Trend (2013–2025)

This chart illustrates how Komipharm International Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Komipharm International Co. Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Komipharm International Co. Ltd ranked by their cash flow conversion efficiency. Explore 041960 cash flow quality score to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Pioneer Bancorp Inc NASDAQ:PBFS	0.012x
Meier Tobler Group AG SW:MTG	-0.019x
Trusval Technology Co Ltd TWO:6667	-0.055x
Qingdao Daneng Environmental Protection Equipment Co Ltd SHG:688501	-0.016x
Atria Oyj A HE:ATRAV	-0.010x
Oportun Financial Corp NASDAQ:OPRT	0.268x
CJ Corp 4P Pref KO:00104K	0.102x
Wuhan Nusun Landscape Co Ltd SHE:300536	0.000x

Annual Cash Flow Conversion Efficiency for Komipharm International Co. Ltd (2013–2025)

The table below shows the annual cash flow conversion efficiency of Komipharm International Co. Ltd from 2013 to 2025. View 041960 stock price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₩72.06 Billion ≈ $48.83 Million	₩-621.80 Million ≈ $-421.39K	-0.009x	-106.39%
2024-12-31	₩65.54 Billion ≈ $44.41 Million	₩8.85 Billion ≈ $6.00 Million	0.135x	+389.35%
2023-12-31	₩60.02 Billion ≈ $40.67 Million	₩-2.80 Billion ≈ $-1.90 Million	-0.047x	-56.46%
2022-12-31	₩60.63 Billion ≈ $41.09 Million	₩-1.81 Billion ≈ $-1.23 Million	-0.030x	-57.78%
2021-12-31	₩66.46 Billion ≈ $45.04 Million	₩-1.26 Billion ≈ $-851.13K	-0.019x	-5819.79%
2020-12-31	₩76.28 Billion ≈ $51.69 Million	₩25.20 Million ≈ $17.08K	0.000x	-97.45%
2019-12-31	₩73.28 Billion ≈ $49.66 Million	₩950.79 Million ≈ $644.34K	0.013x	+160.06%
2018-12-31	₩93.39 Billion ≈ $63.29 Million	₩-2.02 Billion ≈ $-1.37 Million	-0.022x	-1028.56%
2017-12-31	₩101.27 Billion ≈ $68.63 Million	₩235.64 Million ≈ $159.69K	0.002x	-82.06%
2016-12-31	₩93.20 Billion ≈ $63.16 Million	₩1.21 Billion ≈ $819.00K	0.013x	+133.70%
2015-12-31	₩76.13 Billion ≈ $51.59 Million	₩-2.93 Billion ≈ $-1.98 Million	-0.038x	+19.33%
2014-12-31	₩53.16 Billion ≈ $36.02 Million	₩-2.54 Billion ≈ $-1.72 Million	-0.048x	-154.21%
2013-12-31	₩44.72 Billion ≈ $30.31 Million	₩3.93 Billion ≈ $2.67 Million	0.088x	--

About Komipharm International Co. Ltd

KQ:041960 Korea Pharmaceuticals

Market Cap

$370.23 Million

₩546.32 Billion KRW

Market Cap Rank

#13903 Global

#421 in Korea

Share Price

₩9450.00

Change (1 day)

-4.06%

52-Week Range

₩5890.00 - ₩10310.00

All Time High

₩43026.96